Statistical & Clinical Analysis
Sokal and EUTOS CML Scores: Historical Models and Spreadsheet Examples
Explore the original Sokal and EUTOS formulas and how they differ from the current ELTS prognostic approach.
Different scores, different eras
Sokal and colleagues developed a four-variable prognostic model for chronic myeloid leukemia (CML) in 1984, before current tyrosine kinase inhibitor (TKI) treatments. The EUTOS score, published by Hasford and colleagues in 2011, used spleen size and blood basophils at baseline to estimate the likelihood of not achieving a complete cytogenetic response after 18 months of imatinib in the studied population. The two scores do not predict exactly the same outcome.
The original EUTOS grouping used a cutoff of 87: values greater than 87 were the high-risk group for that specific 18-month outcome. Published Sokal groups used <0.8, 0.8–1.2 and >1.2. These study groupings are not a patient-specific certainty, and rounding a value before comparing it with a cutoff can change its group.
The European LeukemiaNet’s 2025 recommendations use the EUTOS Long-Term Survival (ELTS) score for baseline prognosis rather than the older Sokal, Euro and EUTOS scores. ELTS is a separate model. Choosing treatment requires clinical judgment and additional factors, including treatment goals and coexisting conditions; neither spreadsheet output independently determines a drug choice.
Historical EUTOS arithmetic
Enter spleen size below the costal margin in cm in B3 and peripheral-blood basophils as a percentage from 0 to 100 in B4. EUTOS uses pretreatment baseline findings. The formula needs those two values only and does not establish diagnosis or disease phase.
=IF(COUNT(B3:B4)<>2,"Enter numeric spleen size and basophils",IF(OR(B3<0,B4<0,B4>100),"Check input values",ROUND(7*B4+4*B3,1)))Historical Sokal arithmetic
Enter age in years (B2), spleen size in cm (B3), platelets in 10⁹/L (B5) and peripheral blood blasts as a percentage (B6). The formula validates these four numeric inputs, including the 0–100 range for a percentage. It does not determine whether the model is clinically applicable; a blast percentage alone does not establish CML phase.
These are numerical teaching examples, not clinically validated tools. Use original values rather than a rounded display for any research comparison and refer to the original studies and current guidance for context.
=IF(COUNT(B2,B3,B5,B6)<>4,"Enter all four numeric Sokal inputs",IF(OR(B2<=0,B3<0,B5<=0,B6<0,B6>100),"Check input values",ROUND(EXP(0.0116*(B2-43.4)+0.0345*(B3-7.51)+0.188*((B5/700)^2-0.563)+0.0887*(B6-2.1)),3)))Try the example
Use the original values or change them to test your understanding.